Journal Article10.1177/0891988708316858
Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly.
TL;DR: 2 baseline variables, delayed paragraph recall and generalization performance, were predictive of follow-up outcome with sensitivity of 81% and specificity of 91%—better than the classification accuracy based on either of these measures alone.
read more
Abstract: This study examines whether behavioral measures obtained in nondemented elderly can predict cognitive status at 2-year follow-up. Prior studies have established that delayed paragraph recall can help predict short-term risk for decline to mild cognitive impairment and Alzheimer disease. It was examined whether prediction accuracy can be improved by adding a discrimination-and-generalization task that has previously been shown to be disrupted in nondemented elderly with hippocampal atrophy, a risk factor for Alzheimer disease. Fifty nondemented, medically healthy elderly patients received baseline clinical diagnosis and cognitive testing; 2 years later, patients received a follow-up clinical diagnosis of normal, mild cognitive impairment, or probable Alzheimer disease. In all, 2 baseline variables, delayed paragraph recall and generalization performance, were predictive of follow-up outcome with sensitivity of 81% and specificity of 91%-better than the classification accuracy based on either of these measures alone. These preliminary results suggest that these behavioral tasks may be useful tools in predicting short-term cognitive outcome in nondemented elderly.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
Dorene M. Rentz,Mario Parra Rodriguez,Rebecca E. Amariglio,Yaakov Stern,Reisa A. Sperling,Steven H. Ferris +5 more
TL;DR: A selective summary of several novel, potentially promising, approaches that are being explored for detecting early cognitive evidence of preclinical Alzheimer’s disease in presymptomatic individuals.
Individuals With Posttraumatic Stress Disorder Show a Selective Deficit in Generalization of Associative Learning
Einat Levy-Gigi,Szabolcs Kéri,Catherine E. Myers,Zvi Lencovsky,Hadas Sharvit-Benbaji,Scott P. Orr,Mark W. Gilbertson,Richard J. Servatius,Jack W. Tsao,Mark A. Gluck +9 more
TL;DR: Individuals with PTSD show a selective impairment in generalization of past learning similar to other clinical populations with MTL/hippocampal dysfunction, consistent with an emerging view of PTSD as being not only an anxiety disorder but also a learning disorder.
Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research.
Karienn S. Montgomery,Rebecca K. Simmons,George A. Edwards,Michele M. Nicolle,Mark A. Gluck,Catherine E. Myers,Jennifer L. Bizon +6 more
TL;DR: A novel and sensitive paradigm to evaluate mnemonic decline in AD mouse models is described that has unique translational advantages over standard species-specific cognitive assessments (e.g., water maze for rodent and delayed paragraph recall for humans).
32
Depression impairs learning whereas anticholinergics impair transfer generalization in Parkinson patients tested on dopaminergic medications.
Mohammad M. Herzallah,Ahmed A. Moustafa,Adel J. Misk,Lara H. Al-Dweib,Samer A. Abdelrazeq,Catherine E. Myers,Mark A. Gluck +6 more
TL;DR: It is found that comorbid clinical depression impairs initial acquisition, whereas the use of anticholinergic therapy impairs subsequent transfer generalization, suggesting that antichlinergic drugs may particularly impair cognitive abilities that depend on the MT lobe.
Neuropsychological and neurobiological markers of the preclinical stage of Alzheimer's disease
TL;DR: The present review discusses the evidence for markers that identify individuals who are at a high risk of developing Alzheimer's disease and the importance of longitudinal studies in this context.
References
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
Marshal F. Folstein,Marshal F. Folstein,Susan E B Folstein,Susan E B Folstein,Paul R. McHugh,Paul R. McHugh +5 more
TL;DR: A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
86.6K
A practical method for grading the cognitive state of patients for the clinician
Marshal Folstein,Susan E B Folstein,F. Folstein,Paul R. McHugh +3 more
- 01 Jan 2002
TL;DR: The Mini-Mental State (MMS) as mentioned in this paper is a simplified version of the standard WAIS with eleven questions and requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
70.8K
Development of a Rating Scale for Primary Depressive Illness
TL;DR: This is an account of further work on a rating scale for depressive states, including a detailed discussion on the general problems of comparing successive samples from a ‘population’, the meaning of factor scores, and the other results obtained.
8.6K
The Global Deterioration Scale for assessment of primary degenerative dementia.
TL;DR: The authors describe a Global Deterioration Scale for the assessment of primary degenerative dementia and delineation of its stages and have used it successfully for more than 5 years and validated it against behavioral, neuroanatomic, and neurophysiologic measures in patients with primary degeneratives dementia.
5.1K
The consortium to establish a registry for alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer’s disease
John C. Morris,Albert Heyman,Richard C. Mohs,James P. Hughes,G. van Belle,Gerda G. Fillenbaum,E. D. Mellits,C. Clark +7 more
TL;DR: Although information on validation is limited thus far, the CERAD batteries appear to fill a need for a standardized, easily administered, and reliable instrument for evaluating persons with AD in multicenter research studies as well as in clinical practice.
4.1K